0000905718-22-000007.txt : 20220103
0000905718-22-000007.hdr.sgml : 20220103
20220103174554
ACCESSION NUMBER: 0000905718-22-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220103
DATE AS OF CHANGE: 20220103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIKLER MATTHEW
CENTRAL INDEX KEY: 0001195414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38022
FILM NUMBER: 22503276
MAIL ADDRESS:
STREET 1: VIROPHARMA INCORP
STREET 2: 405 EAGLEVIEW BLVD
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc.
CENTRAL INDEX KEY: 0001582554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463011414
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: 908-484-8805
MAIL ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
ownership.xml
X0306
4
2021-12-31
0
0001582554
Matinas BioPharma Holdings, Inc.
MTNB
0001195414
WIKLER MATTHEW
C/O MATINAS BIOPHARMA HOLDINGS, INC.
1545 ROUTE 206 SOUTH SUITE 302
BEDMINSTER
NJ
07921
1
0
0
0
Common Stock
2021-12-31
4
A
0
7859
0
A
290472
D
On December 31, 2021, the Reporting Person was issued 7,859 shares of common stock, par value $0.0001 per share, pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant.
/s/ Keith A. Kucinski, attorney-in-fact for Matthew Wikler
2022-01-03